An atypical subacute presentation of posterior reversible encephalopathy syndrome

References

• Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. The Lancet Neurology;14(9):914–925.
   Web of Science ®Google Scholar
• Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.
   PubMed Web of Science ®Google Scholar
• Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036–1042.
   PubMed Web of Science ®Google Scholar
• Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke. 1997;28(5):1082.
   Web of Science ®Google Scholar
• Schwartz RB, Mulkern RV, Gudbjartsson H, et al. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol. 1998;19(5):859–862.
   PubMed Web of Science ®Google Scholar
• Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320–1327.
   PubMed Web of Science ®Google Scholar
• Baizabal-Carvallo JF, Barragán-Campos HM, Padilla-Aranda HJ, et al. Posterior reversible encephalopathy syndrome as a complication of acute lupus activity. Clin Neurol Neurosurg. 2009;111(4):359–363.
   Web of Science ®Google Scholar
• Ribeiro S, Monteiro M, Moreira B, et al. Rare posterior reversible encephalopathy syndrome in a patient with HIV. BMJ Case Rep. 2013;2013:bcr2013201495.
   Google Scholar
• Kurukumbi M, Castellanos MI, Crawford AK, et al. Posterior reversible encephalopathy syndrome in a patient with newly diagnosed HIV infection and end stage renal disease. Case Rep Neurol Med. 2013;2013:1–5.
   Google Scholar
• Rajasekhar A, George TJJr. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist. 2007;12(11):1332–1335.
   Web of Science ®Google Scholar
• Nightingale S, Wood C, Ainsworth J. The posterior reversible encephalopathy syndrome in HIV infection. BMJ Case Rep. 2012;2012: bcr0120125647. doi:10.1136/bcr.01.2012.5647.
   Google Scholar
• Legriel S, Pico F, Azoulay E. Understanding posterior reversible encephalopathy syndrome. In: Vincent J-L, editor. Annual update in intensive care and emergency medicine 2011. Berlin, Heidelberg: Springer; 2011. p. 631–653.
   Google Scholar
• Chang OH-C, Stanculescu A, Dola C, et al. Recurrent posterior reversible encephalopathy syndrome potentially related to AIDS and end-stage renal disease: a case report and review of the literature. Case Rep Med. 2012;2012:1–3.
   Google Scholar
• Abbott NJ, Patabendige AAK, Dolman DEM, et al. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25.
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1–13.
   PubMed Web of Science ®Google Scholar
• Tai H, Lai H, Jani J, et al. HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans. Int J Cardiol. 2012;161(2):83–87.
   Web of Science ®Google Scholar
• Andras IE, Pu H, Deli MA, et al. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res. 2003;74(2):255–265.
   PubMed Web of Science ®Google Scholar
• Tanioka R, Yamamoto Y, Sakai M, et al. Convalescence of atypical reversible posterior leukoencephalopathy syndrome in human immunodeficiency virus infection. J Med Invest. 2007;54(1–2):191–194.
   Google Scholar
• Sasson SC, Oon A, Chagantri J, et al. Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report. BMC Infect Dis. 2013;13:396.
   Web of Science ®Google Scholar
• Guerriero S, Ciracì L, Centoducati T, et al. Bilateral visual loss as presenting symptom of posterior reversible encephalopathy syndrome in a patient with HIV/tuberculosis coinfection: a case report. Case Rep Ophthalmol Med. 2012;2012:1–4.
   Google Scholar
• Saeed MU, Dacuycuy MAC, Kennedy DJ. Posterior reversible encephalopathy syndrome in HIV patients: case report and review of the literature. AIDS. 2007;21(6):781–782.
   Web of Science ®Google Scholar
• Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254(1):78–101.
   PubMed Web of Science ®Google Scholar
• Prasad A, Kulkarni R, Jiang S, et al. Cocaine enhances DC to T-cell HIV-1 transmission by activating DC-SIGN/LARG/LSP1 complex and facilitating infectious synapse formation. Sci Rep. 2017;7:40648.
   Web of Science ®Google Scholar
• Dahal S, Chitti SVP, Nair MPN, et al. Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS. Front Microbiol. 2015;6:931.
   Web of Science ®Google Scholar
• Dalvi P, Wang K, Mermis J, et al. HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway. PLoS One. 2014;9(1):e85246.
   Web of Science ®Google Scholar
• Bazuaye-Ekwuyasi EA, Ogunbileje JO, Kaphalia BS, et al. Comparative effects of cocaine and cocaethylene on alveolar epithelial type II cells. Toxicology Mechanisms and Methods 2015;25(8):604–613.
   Google Scholar
• Cerretani D, Fineschi V, Bello S, et al. Role of oxidative stress in cocaine-induced cardiotoxicity and cocaine-related death. Curr Med Chem. 2012;19(33):5619–5623.
   PubMed Web of Science ®Google Scholar
• Tacker DH, Okorodudu AO. Evidence for injurious effect of cocaethylene in human microvascular endothelial cells. Clin Chim Acta. 2004;345(1–2):69–77.
   Web of Science ®Google Scholar
• Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. BMJ. 2016;1:83–92.
   Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838.
   PubMed Web of Science ®Google Scholar